VialTalk
VialTalk

Superseded. Newer COA available for this product: view newer COA.

TriVial BioWorks logo

Triple Agonist 10mg — Verification Report

From TriVial BioWorks · Lot RT10-0529 · Tested May 2026

← Back to TriVial BioWorks
VialTalk
Verification report

Triple Agonist 10mg

TriVial BioWorks

Score
102.5
Grade
A++
Superlative
Lot RT10-0529
Tested May 2026
Report ID
4fe37547
PurityFull credit
HPLC
99.47%
IdentityFull credit
Mass spectrometry
Confirmed
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
10 mg labeled · 12.97 mg tested
EndotoxinFull credit
USP <85> compendial
Screened
Heavy metalsFull credit
ICP-MS
Screened
SterilityNot submitted
Not tested
Not tested
Batch conformityNot submitted
Not tested
Not tested
Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →